Key result
Adjunctive coronary endarterectomy in diffuse coronary artery disease demonstrated an operative mortality of 2.62% and a median survival time of 16.67 years (95% CI 15.14-18.19 years).
Why the study?
Does coronary endarterectomy as an adjunct to CABG provide acceptable long-term survival in patients with diffuse coronary artery disease?
Cohort (n=801)
No
Does coronary endarterectomy as an adjunct to CABG provide acceptable long-term survival in patients with diffuse coronary artery disease?
Adjunctive coronary endarterectomy during CABG in diffuse coronary artery disease provides significant long-term survival with low operative mortality.
Endarterectomy was associated with low mortality and long survival in diffuse CAD; hypothesis-generating pending randomized confirmation.
OBJECTIVES: The role of coronary endarterectomy (CE) in modern cardiac surgery has been an extant debate as coronary artery bypass grafting (CABG) has advanced. However, as cardiac surgeons are being referred ever more complex coronary disease for surgical correction, adjunctive strategies may need re-evaluation. The long-term results of CE are largely unknown. We present the longest cohort follow-up in a single institution looking at our 20-year experience of CEs employed as an adjunct to CABG in diffuse coronary artery disease. METHODS: We performed retrospective analysis of data collected prospectively on 801 patients undergoing CEs between February 1988 and September 2010 by a single surgeon using a standard open hydrodissection technique. We looked at patient demographics, characteristics of the vessels subjected to endarterectomy and predictors of long-term survival within this surgical group using Cox's regression analysis. RESULTS: The mean age was 63.2 (±9.6) years. The mean number of coronary arteries undergoing endarterectomy was 1.16 (±0.4) per patient. Of these, 63.7% were performed on the right coronary artery (n = 558) and 32.3% on the left anterior descending artery (n = 283). The operative mortality was 2.62% (n = 21). The median survival time was 16.67 years (95% confidence interval 15.14-18.19 years). The significant predictors of survival (P < 0.05) were a lower age at surgery, a lower EuroSCORE I, the absence of peripheral vascular disease and shorter bypass times. CONCLUSION: This significant long-term survival demonstrates that CE can be an attractive adjunct to CABG in otherwise inoperable coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Ariyaratnam et al. (2012) conducted a cohort in Diffuse coronary artery disease (n=801). Coronary endarterectomy (CE) as an adjunct to CABG was evaluated on Median survival time (95% CI 15.14-18.19). Adjunctive coronary endarterectomy in diffuse coronary artery disease demonstrated an operative mortality of 2.62% and a median survival time of 16.67 years (95% CI 15.14-18.19 years).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: